Keryx Biopharmaceuticals
In Seth Klarman's portfolio · Baupost Group
Ticker KERX
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Baupost Group 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q4 2018 | Sell | 0 | |
| Q3 2018 | No change | 25,791,678 | 0.7% |
| Q2 2018 | No change | 25,791,678 | 0.8% |
| Q1 2018 | No change | 25,791,678 | 1.0% |
| Q4 2017 | No change | 25,791,678 | 1.2% |
| Q3 2017 | No change | 25,791,678 | 2.3% |
| Q2 2017 | No change | 25,791,678 | 2.1% |
| Q1 2017 | No change | 25,791,678 | 1.9% |
| Q4 2016 | No change | 25,791,678 | 2.0% |
| Q3 2016 | No change | 25,791,678 | 1.9% |
| Q2 2016 | No change | 25,791,678 | 2.3% |
| Q1 2016 | No change | 25,791,678 | 1.7% |
| Q4 2015 | No change | 25,791,678 | 2.4% |
| Q3 2015 | No change | 25,791,678 | 1.4% |
| Q2 2015 | Add 15% | 25,791,678 | 4.3% |
| Q1 2015 | Add 22% | 22,380,200 | 4.8% |
| Q4 2014 | No change | 18,300,000 | 5.1% |
| Q3 2014 | Add 74% | 18,300,000 | 4.4% |
| Q2 2014 | Add 67% | 10,539,986 | 2.6% |
| Q1 2014 | Buy | 6,310,850 | 2.6% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.